2. PRESENT PROFESSIONAL POSITIONS. 5. ADVISORY BOARDS and RESEARCH COMMITTEES. 10. TEACHING ACTIVITIES and INVITED LECTURES


Save this PDF as:
 WORD  PNG  TXT  JPG

Tamaño: px
Comenzar la demostración a partir de la página:

Download "2. PRESENT PROFESSIONAL POSITIONS. 5. ADVISORY BOARDS and RESEARCH COMMITTEES. 10. TEACHING ACTIVITIES and INVITED LECTURES"

Transcripción

1 C. Vitae Jordi Monés 1 CURRICULUM VITAE, February, 2014 Jordi M. Monés PERSONAL DATA. 1. EDUCATION / QUALIFICATIONS 2. PRESENT PROFESSIONAL POSITIONS 3. PAST POSITIONS 4. INTERNATIONAL AWARDS 5. ADVISORY BOARDS and RESEARCH COMMITTEES 6. GRANTS 7. CLINICAL TRIALS 8. SCIENTIFIC PUBLICATIONS 9. SCIENTIFIC PRESENTATIONS 10. TEACHING ACTIVITIES and INVITED LECTURES 11. COLLABORATION IN JOURNALS EDITION and REVIEWER 12. SCIENTIFIC SOCIETIES MEMBERSHIP 13. LANGUAGES

2 C. Vitae Jordi Monés 2 PERSONAL DATA: Name: Address: Jordi Manel Monés i Carilla (Jordi M. Monés) Institut de la Màcula i de la Retina Centro Médico Teknon Consultoris Vilana. Àrea desp. 90 Vilana 12, Barcelona SPAIN Telephone Fax E- mail: Web: Date of Birth: Barcelona, June 25, EDUCATION / QUALIFICATIONS: / /1985: LICENCIATE IN MEDICINE AND SURGERY. Qualification: Excellent. University of Barcelona. Barcelona, SPAIN /1986: SPANISH NATIONAL BOARD EXAMINATION for a Residency Position M.I.R.1985/6: National classification number: /86-12/1989: RESIDENCY IN OPHTHALMOLOGY, (Opthalmologist M.I.R.) Barraquer Institute, Barcelona, SPAIN / /1991: RESEARCH FELLOWSHIP IN OPHTHALMOLOGY (RETINA SERVICE). Massachusetts Eye and Ear Infirmary, Harvard University. Boston, U.S.A.

3 C. Vitae Jordi Monés / /1992: SURGICAL VITREORETINAL FELLOWSHIP. CLINICAL AND SURGICAL RETINA FELLOWSHIP. Retina Department, Hospital San José. Instituto Tecnológico y de Estudios Superiores de Monterrey (ITESM). Monterrey, MEXICO / /2012: DOCTORAL THESIS, Ph.D. Degree. DOCTOR IN MEDICINE AND SURGERY, Qualification: Cum Laude. University of Barcelona, SPAIN. 2. PRESENT PROFESSIONAL POSITIONS: 2.1. CURRENT: M.D., Ph.D., Opthalmologist, Macula and Retina Specialist. Macular and Retinal Degeneration Researcher Founder and Director of Institut de la Màcula i de la Retina Centro Médico Teknon, Consulta 90, Vilana 12, Barcelona Founder and Medical Director of the Barcelona Macula Foundation: Research for Vision Elected Coordinator of the Specialty of Ophthalmology at the Centro Médico Teknon Feb 12 Feb Institut de la Màcula i de la Retina Acredited site of the network of excellence in research, European Vision Institute Elected Member of AMD and Retinal Dystrophies Expert Committee of the European Vision Clinical Research Netwwork (EVICR.net) Scientific Advisory Boards Member of the Scientific Advisory Board of AMD international Alliance

4 C. Vitae Jordi Monés Member of the Region Europe Ophthalmics Network (REONET) advisory board, Novartis Member of the European Advisory Board on Retinal Vein Occlusion, ERAB, Allergan Inc Scientific Advisor of Opththech Inc, New York USA Scientific Advisor of Notalvision Inc, Tel Aviv, Israel Member of the International Advisory Board for Eylea (VEGF- Trap eye) Bayer Schering Pharma Other positions: Current Member of the Board of Directors (Junta Directiva ) of FUTBOL CLUB BARCELONA. Responsible of the Medical and Sport Performance Department of Futbol Club Barcelona 3. PAST POSITIONS: Consultant as Vitreoretinal Specialist Ophthalmologist in: 3.1. Institut de Microcirurgía Ocular de Barcelona. (April December 2006) 3.2. Hospital de la Creu Roja de Barcelona ( Nov 2004), Consultant Ophthalmology Service. Vitreoretinal Surgery Associate Profesor Universitat Autònoma de Barcelona in: ( ) Cátedra (Professorship) Institut de Microcirurgia Ocular de Barcelona Universitat Autónoma de Barcelona 3.4. Member of the Board of Directors (Junta Directiva) of FUTBOL CLUB BARCELONA. Responsible of the Medical and Sport Medicine Department of Futbol Club Barcelona. June 03 - June 05

5 C. Vitae Jordi Monés Elected Coordinator of the Specialty of Ophthalmology at the Centro Médico Teknon. Feb 10 - Feb 12 Main Fields of professional interests: Macular diseases, choroidal neovascularization, exudative age-related macular degeneration, antiangiogenesis, antiangiogenic therapy, anti platelet-derived growth factor therapy, dry age-related macular degeneration geographic atrophy, retinal degeneration, chorioretinal dystrophies, choroidal circulation, retinal transplant, neural and mesenchymal stem cells, genetics in retinal degeneration, diabetic retinopathy, macular edema, vitreoretinal surgery, macular surgery, photodynamic therapy, fundus imaging, fundus microperimetry. 4. INTERNATIONAL AWARDS: 4.1. Co-Winner of the INTERNATIONAL AWARD OF EXPERIMENTAL SURGERY Banc de Sabadell, Acadèmia de Medecina de Barcelona, i Col.legi Oficial de Metges de Barcelona, with the Research Project: "Photodynamic Therapy of the Experimental Posterior Malignant Melanoma" (Massachusetts Eye and Ear Infirmary, Harvard University, Boston, USA. Director of the Project: Evangelos Gragoudas MD). Barcelona, June 18, Premi a la Recerca Científica en DMAE. Associació Discapacitat Visual de Catalunya. 30 Novembre ADVISORY BOARDS AND RESEARCH COMMITTEES : Rotating Member of Study Advisory Group of the Randomized, Placebo-Controlled, Masked, Multicenter, Phase III b Study of the Treatment of the Subfoveal Neovascularization Secondary to Age-Related Macular Degeneration and pathologic myopia Using Photodynamic Therapy with Liposomal BPD-MA Verteporfin Institut de Microcirurgia Ocular de Barcelona.

6 C. Vitae Jordi Monés : Rotating Member of Study Advisory Group of the Photodynamic Therapy using Verteporfin Study VER, VIO and VIM. Institut de Microcirurgia Ocular de Barcelona : Member of the International Consultant Committee for Research in AMD, Novartis International, Basel, Switzerland : Member of the International Council for Research of Retinal Diseases of Eyetech Co. New York, USA Ongoing: Scientific Consultant of Notalvision, Co. Tel-Aviv, Israel : Member of the Macula Society Research Committee Allergan advisory board. Annual Meeting Association for Research in vision and ophthalmology, Fort Lauderdale, USA. May Advisory Board Meeting Ophthotech for new treatments for exudative and Dry AMD London, 30 and 31 October, London Advisory board Allergan for Posurdex device for the treatment of macular edema secondary to retinal vein occlusion and diabetic macular edema. American Academy of Ophthalmology, November 9. Atlanta, USA Advisory Board for Preferential Hyperacuity Perimeter. Notalvision, Israel (from 2008 please see in section 11.2) 6. GRANTS: 6.1. FUNDACIÓN RICH (Madrid, Spain): Year 1990, ptas for 1 year of Vitreoretinal Researh Fellowship in the Massachusetts Eye and Ear Infirmary, Harvard University, Boston USA Beca FISS, Ministerio de Sanidad y Consumo

7 C. Vitae Jordi Monés 7 7. CLINICAL TRIALS : Principal Investigator of a multicentric, ranndomized, doble-masked clinical trial with 60 patients enrolled "Diclofenac colirio versus Dexametasona colirio en el Tratamiento de Estados Inflamatorios no Quirúrgicos del Segmento Anterior del Ojo sin Infección. Centre d Oftalmologia Barraquer : Principal Investigator of a Randomized, Placebo-Controlled, Masked, Multicenter, Phase III Study of the Treatment of the Subfoveal Neovascularization Secondary to Age-Related Macular Degeneration Using Photodynamic Therapy with Liposomal BPD-MA Verteporfin. Institut de Microcirurgia Ocular de Barcelona : Principal Investigator of a Randomized, Placebo-Controlled, Masked, Multicenter, Phase III b Study of the Treatment of the Subfoveal Neovascularization Secondary to Age-Related Macular Degeneration and pathologic myopia Using Photodynamic Therapy with Liposomal BPD-MA Verteporfin. Institut de Microcirurgia Ocular de Barcelona : Principal Investigator of the Study VER: Multicenter, Randomized, Parallel Group, Double Mask, Controlled Phase IIIb, 2-year Study comparing the Efficacy and Safety of VISUDYNE TM Therapy with Early Retreatment to Standard Treatment in Predominantly Classic Subfoveal Choroidal Neovascularization. Institut de Microcirurgia Ocular de Barcelona : Principal Investigator of the Clinical Trial: Eyetech Pharmaceuticals Phase II/III Clinical Trial with Anti-VRGF Pegylated Aptamer (EYE001) in patients with Exudative Age-Related Macular Degeneration. Institut de Microcirurgia Ocular de Barcelona : Principal Investigator of the Clinical Trial: Prospective Clinical Trial of VisionCare Ophthalmic Technologies Inc s Implantable Miniature Telescope (IMT TM ) for Patients with Age-Related Macular Degeneration Institut de Microcirurgia Ocular de Barcelona.

8 C. Vitae Jordi Monés : Principal Investigator of the Clinical Trial: An Evaluation of Safety and Efficacy of Anecortave Acetate Sterile Suspension Following Sub- Tenon s Injections for the Inhibition of Neovascularization in Patients With Exudative Age-Related Macular Degeneration. Institut de Microcirurgia Ocular de Barcelona : Principal Investigator, Preferential Hyperacuity Perimetry Evaluation for Treatrment with Photodynamic Therapy of choroidal neovascularization. Institut de Microcirurgia Ocular de Barcelona : Co-Investigator, Estudio multicéntrico, fase III, enmascarado, aleatorizado, controlado con simulador, con una duración de 6 meses (con extensión abierta de 6 meses) para evaluar la seguridad y eficacia del sistema aplicador DEX PS DDS (Sistema de liberacion del fármaco dexametasona en el segmento posterior) de 700 microgr y 350 microgr en el tratamiento de pacientes con edema macular después de la oclusión de la vena central de la retina u oclusión de la rama de la vena central de la retina. Institut de Microcirurgia Ocular (IMO) : Principal Investigator, ENSAYO fase 3B, aleatorizado, controlado con tratamiento activo, doble ciego, con simulación simple, multicéntrico, comparativo y de grupos paralelos, para comparar la seguridad y la eficacia de inyecciones intravítreas de Macugen administradas cada 6 semanas durante 54 semanas (que pueden ampliarse hasta 102 semanas si está indicado) más terapia fotodinámica (TFD) simulada, frente a Macugen más TFD con VISUDYNE, en sujetos con neovascularización coroidea (NVC) subfoveal predominantemente clásico secundaria a la degeneración macular relacionada con la edad (DMAE) estudio : Co-investigator. VERTA V1. Institut de Microcirurgia Ocular (IMO), Novartis EudraCT: : Principal Investigator, Evaluación internacional de la carga de enfermedad de la degeneración macular exudativa subfoveal

9 C. Vitae Jordi Monés 9 asociada a la edad. Institut de Microcirurgia Ocular (IMO) SOA/COV 2627/ BC Pfizer/ Covance : Principal Investigator, Estudio de fase III, multicéntrico, aleatorizado, controlado, con doble enmascaramiento de lactato de escualamina (MSI-1256F) en inyección para el tratamiento de la neovascularización coroidea subfoveal asociada a degeneración macular asociada a la edad. Institut de Microcirurgia Ocular (IMO), Genaera Corporation, MSI-1256F : Principal investigator. Ensayo de reducción de riesgo con acetoato de anecortave (AART) Evaluación de la eficacia y seguridad de la administración yuxtqexcleral posterior de acetato de anecortave para suspensión depot ( 15mg o 30mg ), comparado con la administración sdimulada en pacientes ( participantes en el estudi "A" o en esl estudio "B") con riesfgo de desarrollar neovasc coroidea (CNV ) con amenaza a la visión debido a degeneración macular asociada a la edad ( AMD ) Alcon C : Pegaptanib en DMAE exudativa temprana comparada con DMAE exudativa no temprana : Ranibizumab Estudio EXCITE en DMAE exudativa : Ongoing Promoter and Principal Investigator Raneovasc: ensayo clínico de fase ii, prospectivo, controlado, abierto, aleatorizado con grupos paralelos para comparar la seguridad y la eficacia del ranibizumab en monoterapia frente a la combinación con terapia fotodinámica con verteporfina (TFDV) en pacientes con neovascularización coroidea (NVC) subfoveal secundaria a la degeneración macular asociada a la edad (DMAE) : Principal Investigator Estudio de fase 3, aleatorizado, doble enmascarado, con asignación paralela de bevasiranib sódico intravítreo administrado cada 8 ó 12 semanas como terapia de mantenimiento tras 3 inyecciones de Lucentis, comparado con monoterapia

10 C. Vitae Jordi Monés 10 con Lucentis cada 4 semanas en pacientes con Degeneración Macular Exudativa Asociada a la Edad. Promotor: OPKO Health : Co-investigator Estudio VIEW-2. Estudio de fase 3, randomizado, doble enmascarado, con grupo control, para evaluar la eficacia y seguridad de inyecciones intravítreas repetidas de VEGF-Trap en pacientes con degeneración macular asociada a la edad exudativa. Promotor: Bayer. Investigadors: Lluis Arias, Jordi Monés : Co-investigator Estudio TG-MV-007. Estudio de fase 3, multicéntrico, con doble enmascaramiento, controlado con placebo y aleatorizado de la inyección intravítrea de microplasmina para el tratamiento no quirúrgico de la adherencia vitreomacular focal. Promotor: Thrombogenics. Investigadors: Lluis Arias, Jordi Monés : Ongoing Principal investigator and protocol co-designer. A phase 1 study to establish the safety and tolerability of arc1905 (anti-c5 aptamer) in subjects with dry age-related macular degeneration with geographic atrophy : Ongoing Principal investigator and protocol co-designer: An open-label investigator research grant trial Phase II to establish the safety of intravitreous injections of E10030 (anti-pdgf pegylated aptamer) given in combination with Lucentis in NON RESPONDERS subjects with neovascular age-related macular degeneration. Protocol Number E Investigators: Jordi Monés : Ongoing Principal investigator Ensayo Fase II, randomizado, doble enmascarado, controlado, para establecer la seguridad y la eficacia de inyecciones intravítreas de E10030 (aptámero pegilado anti-pdgf) administrado en combinación con Lucentis en sujetos con Degeneración Macular Asociada a la Edad forma Neovascular. Protocolo nº OPH Ongoing: Investigador principal i co-dissenyador de protocol Assaig obert de recerca per concedir assaig en Fase II, per establir la seguretat de les injeccions intravítreas de E10030 (anti-pdgf aptàmers

11 C. Vitae Jordi Monés 11 pegilat) en combinació amb Lucentis en subjectes no responedors amb DMAE neovascular. Protocol Número E Ongoing: Investigador principal ensayo clínico piloto de fase II, unicéntrico, para evaluar la seguridad del trasplante de retina fetal humana en el tratamiento de la degeneración macular asociada a la edad de tipo seca con atrofia geográfica y la retinosis pigmentaria. Institut de la Màcula i de la Retina, Barcelona Macula Foundation Ongoing: Principal Investigator and Steering committee member Crystal: A 24-month, phase IIIb, open-label, single arm, multicenter study assessing the efficacy and safety of individualized, stabilization criteria-driven pro re rata (PRN) dosing regimen with 0.5-mg ranibizumab intravitreal injections applied as monotherapy to patients with visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO). Promotor: Novartis. Institut de la Màcula i de la Retina, Barcelona Macula Foundation Ongoing: Principal Investigator and Steering committee member Brighter: A 24-month, phase IIIb, randomized, active-controlled, three-arm, multicenter study assessing the efficacy and safety of an individualized, stabilization criteria driven PRN dosing regimen with 0.5 mg ranibizumab intravitreal injections applied as monotherapy or with adjunctive laser photocoagulation in comparison to laser photocoagulation in patients with visual impairment due to macular edema secondary to branch retinal vein occlusion (BRVO). Promotor: Novartis. Institut de la Màcula i de la Retina, Barcelona Macula Foundation Ongoing: Investigador principal, Estudio Mega Omega for drusen: estudio fase II, randomizado, doble enmascarado, para establecer la seguridad y la eficacia de altas dosis orales de Omega-3 en sujetos con drusas de alto riesgo secundarias a degeneración macular asociada a la edad. Institut de la Màcula i de la Retina, Barcelona Macula Foundation.

12 C. Vitae Jordi Monés Ongoing - Investigador principal Estudio Mega Omega for dry: estudio fase II, randomizado, doble enmascarado, para establecer la seguridad y la eficacia de altas dosis orales de Omega-3 en sujetos con atrofia geográfica secundaria a degenaración macular asociada a la edad. Institut de la Màcula i de la Retina, Barcelona Macula Foundation Ongoing: Principal Investigator, The geographic atrophy in pig study (the gap study): a phase iescalating dose of subretinal sodium iodate in pig: a toxic-induced animal model of geographic atrophy of rpe and photoreceptors. Institut de la Màcula i de la Retina, Barcelona Macula Foundation Ongoing: Principal Investigator, The MPL4 Drusen Study a phase 1 study to establish the safety and efficacy of retinal pigment epithelium micropulse laser in subjects with high risk drusen secondary to age-related macular degeneration. Institut de la Màcula i de la Retina, Barcelona Macula Foundation Ongoing: Principal Investigator, The MPL4 Dry Study a phase 1 study to establish the safety and efficacy of retinal pigment epithelium micropulse laser in subjects with geographic atrophy secondary to dry agerelated macular degeneration. Institut de la Màcula i de la Retina, Barcelona Macula Foundation 8. SCIENTIFIC PUBLICATIONS: 8.1. Editor/Author Book: Degeneración Macular Asociada a la Edad. J Monés, F Gómez Ulla (eds) Barcelona, Prous Science, Autor Book Chapters: Monés i Carilla J, Friedman E: Angiografia coroidea con indocianina verde en la degeneración macular asociada con la edad. In: La Mácula Senil. Gómez-Ulla F (ed). Ciba Visión, Barcelona, 5: 75, 1993.

13 C. Vitae Jordi Monés Monés JM, Guyer DR, Puliafito CP: Indocyanine green angiography. In: Principles and Practice of Ophthalmology. Albert DM, Jakobiec FA (eds). Philadelphia, WB Saunders, (2) 52: 718, Monés i Carilla J: Videoangiografía con indocianina verde mediante Scanning Laser Ophthalmoscope: Generalidades. In: Nuevos Métodos de Exploración retiniana. Gómez-Ulla F (ed). Sociedad Española de Oftalmología, Madrid, 3: 37, Monés i Carilla J: Videoangiografía con indocianina verde mediante Scanning Laser Ophthalmoscope en la DMAE. In: Nuevos Métodos de Exploración retiniana. Gómez-Ulla F (ed). Sociedad Española de Oftalmología, Madrid, 6: 67, Monés JM, Slakter J: Indocyanine Videoangiography in Serpiginous Choroidopathy. IN: Indocyanine Green Angiography. Yannuzzi LA, Flowe RW, Slakter JS. St. Louis, Mosby, (17): 247, Monés JM. Luxación posterior de lentes intraoculares. In: Corcóstegui B (Eds) Sociedad Española de Oftalmología. Torremolinos, September Monés JM, Guyer DR, Puliafito CP: Indocyanine green angiography. In: Principles and Practice of Ophthalmology. 2 nd edition Albert DM, Jakobiec FA (eds). Philadelphia, WB Saunders, (2) 52: 718, Monés JM. PDT for miopía. In: Photodynamic Therapy of Ocular Diseases. Gragoudas ES, Miller JW, Zografos L (eds). Lippincot, Williams & Wilkins. Philadelplhia Monés JM, Loewenstein A. Perimetría de Hiperagudeza Preferencial. In: Degeneración Macular Asociada a la Edad. J Monés, F Gómez Ulla (eds) Barcelona, Prous Science, Arias L, Monés JM. Terapia Fotodinámica em DMAE. In: Degeneración Macular Asociada a la Edad. J Monés, F Gómez Ulla (eds) Barcelona, Prous Science, 2005.

14 C. Vitae Jordi Monés Mateo C, Pérez Belmonte L, Navarro R, Monés J. Translocación macular. In: Degeneración Macular Asociada a la Edad. J Monés, F Gómez Ulla (eds) Barcelona, Prous Science, Monés JM, Guyer DR, Puliafito CP. Indocyanine green angiography. In: Principles and Practice of Ophthalmology. Albert DM, Jakobiec FA (eds). 2 nd edition Philadelphia, WB Saunders, Fundus autofluorescence patterns and optical coherence tomography in geographic atrophy secondary to AMD"AMD. Revision book". Silva R et al. Ed Théa, 2010 (at the publisher) Jonas J, Paques M, Monés J, Glacet-Bernard A. Retinal Vein Occlusion. Macular Edema. Ed. Gab riel Coscas (at the publisher) Loewenstein A, Zur D, Tufail A, Monés J. Postsurgical cystoid macular edema. Retinal Vein Occlusion. Macular Edema. Ed. Gabriel Coscas (at the publisher) 8.3. Spanish Scientific Journals: Vilaplana i Blanch D, Soler i Tomàs JR, Monés i Carilla JM, Sena i Dutrenit JM. Profilaxis del desprendimiento de la retina. Fotocoagulación con làser. Revista d'or d'oftalmologia, Soler i Tomàs JR, Vilaplana i Blanch D, Monés i Carilla JM, Sena i Dutrenit JM. Estudio comparativo làser Argon versus Krypton rojo en el tratamiento de la coroidorretinopatía central serosa. Revista d'or d'oftalmologia, International Scientific Journals: Monés JM, Woods WJ, Puliafito CA. Retinal toxicity of hyaluronidase and thimerosal injected into the vitreous body of the rabbit. Invest Ophthalmol Vis Sci 32 (4) (Suppl): 879, 1991.

15 C. Vitae Jordi Monés Bauman WC, Monés JM, Tritten JJ, Lin CP, Gragoudas E, Puliafito CA. Transpupillary phthalocyanine photodynamic therapy of experimental posterior malignant melanoma. Invest Ophthalmol Vis Sci 32 (4) (Suppl): 713, Puliafito CA, Guyer DR, Monés JM, Weaver Y. Indocyanine-Green Digital Angiography and Dye-Enhanced Diode Laser Photocoagulation of Choroidal Neovascularization. Invest Ophthalmol Vis Sci 32 (4) (Suppl): 712, Guyer DR, Puliafito CA, Monés JM, et al. Indocyanine-green digital angiography in chorioretinal disorders. Ophthalmol 99: 287, Corcóstegui B, Monés JM. Indocyanine videangiography with Scanning Laser Ophthalmoscope of large choroidal vessels in exudative agerelated macular degeneration. Invest Ophthalmol Vis Sci 35 (4) (Suppl): 1507, Monés J and the VIP Study Group. Photodynamic therapy (PDT) with Verteporfin of subfoveal choroidal neovascularization in age-related macular degeneration: Study design and baseline characteristics in the VIP randomized clinical trial. Invest Ophthalmol Vis Sci 40 (4) (Suppl): TAP Study Group (Jordi Monés is the writing Committee). Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group: Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration with Verteporfin. One-Year Results of 2 Randomized Clinical Trials TAP Report 1. Arch Ophthalmol 1999; 117: TAP Study Group (Jordi Monés as is the writing Committee). Case series of VA improvements following PDT with Verteporfin fon CNV in AMD (In preparation)

16 C. Vitae Jordi Monés TAP Study Group (Jordi Monés as is the writing Committee). Photodynamic therapy of subfoveal choroidal neovascularization in agerelated macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 2001 Feb;119(2): VIP Study Group (Jordi Monés as is the writing Committee). Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Pathologic Myopia with Verteporfin. Two-year Vision Results of 2 Randomized Clinical Trials. VIP report 1. Ophthalmology 2001 May;108(5): VIP Study Group (Jordi Monés as is the writing Committee). Verteporfin Therapy of Subfoveal choroidal neovascularization in agerelated macular degeneration: two-year results of a randomised clinical trial including lesions with occult with no classic choroidal neovascularization verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001 May, 131 (5): Verteporfin Roundtable 2000 and 2001 Participants; Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group principal investigators; Verteporfin in photodynamic therapy (VIP) study group principal investigators. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina Feb;22(1): VIP Study Group (Jordi Monés as is the writing Committee). Letter to the Editor of the American Journal of Ophthalmology regarding additional data relevant to VIP Report Blumenkranz MS, Bressler NM, Bressler SB, Donati G, Fish GE, Haynes LA, Lewis H, Miller JW, Mones JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Schachat AP, Schmidt-Erfurth U, Sickenburg M,

17 C. Vitae Jordi Monés 17 Singerman LJ, Slakter JS, Strong A, Vannier S; Treatment of Age- Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--tap Report no. 5. Arch Ophthalmol Oct;120(10): Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-tap report No. 3. Arch Ophthalmol Nov;120(11): Barbazetto I, Burdan A, Bressler NM, Bressler SB, Haynes L, Kapetanios AD, Lukas J, Olsen K, Potter M, Reaves A, Rosenfeld P, Schachat AP, Strong HA, Wenkenstern A; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--tap and VIP report No. 2. Arch Ophthalmol Sep;121(9): Blinder KJ, Blumenkranz MS, Bressler NM, Bressler SB, Donato G, Lewis H, Lim JI, Menchini U, Miller JW, Monés JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld P, Schachat AP, Schmidt-Erfurth U, Sickenberg M, Singerman LJ, Slakter JS, Strong HA, Virgili G, Williams GA. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-vip report no. 3. Ophthalmology Apr;110(4):

18 C. Vitae Jordi Monés TAP Study Group (Jordi Monés as is the writing Committee). Blinder KJ, Bradley S, Bressler NM, Bressler SB, Donati G, Hao Y, Ma C, Menchini U, Miller J, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Strong HA, Stur M, Su XY, Virgili G; Treatment of Age-related Macular Degeneration with Photodynamic Therapy study group; Verteporfin in Photodynamic Therapy study group. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to agerelated macular degeneration: TAP and VIP report no. 1. Am J Ophthalmol Sep;136(3): Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Monés J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study GroupVerteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study. Report no. 4. Retina Feb;24(1): (Jordi Monés as in the Writing Committee). Pegaptanib for Neovascular Age-Related Macular Degeneration. Evangelos S. Gragoudas, M.D., Anthony P. Adamis, M.D.,Emmett T. Cunningham, Jr., M.D., Ph.D., M.P.H., Matthew Feinsod, M.D.,and David R. Guyer, M.D., for the VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. n engl j med 351;27 December 30, Monés J, Rubin GS. Contrast sensitivity as an outcome measure in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration. Eye (Lond) Nov;19(11): Review.

19 C. Vitae Jordi Monés TAP Study Group (Jordi Monés as in the writing Committee). Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age- Related Macular Degeneration: Four-Year Results of an Open-Label Extension of 2 Randomized Clinical Trials: TAP Report No. 7 Arch Ophthalmol. 2005;123: Chakravarthy U, Soubrane G, Bandello F, Chong V, Creuzot- Garcher C, Dimitrakos SA 2nd, Korobelnik JF, Larsen M, Monés J, Pauleikhoff D, PournarasCJ, Staurenghi G, Virgili G, Wolf S. Evolving European guidance on the medical management of neovascular age related macular degeneration.br J Ophthalmol Sep;90(9): Monés J. New perspectives on the treatment of age-related macular degeneration. Drugs Today (Barc) Nov;41(11): Monés JM, Lopez MA, Prieto JA, Rodriguez JP.Extrafoveal choroidal neovascularization secondary to wet age-related macular degeneration treated with intravitreal bevacizumab.ophthalmic Surg Lasers Imaging May-Jun;38(3): Monés J [Bevacizumab or Ranibizumab, or the tale of Robin Hood and King Richard Lion Heart.]Arch Soc Esp Oftalmol Sep;82(9): Spanish. No abstract available. PMID: [PubMed - in process] Soubrane G, Cruess A, Lotery A, Pauleikhoff D, Monés J, Xu X, Zlateva G, Buggage R, Conlon J, Goss TF. Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Arch Ophthalmol Sep;125(9): Cruess AF, Zlateva G, Xu X, Soubrane G, Pauleikhoff D, Lotery A, Monés J, Buggage R, Schaefer C, Knight T, Goss TF. Economic burden of bilateral neovascular age-related macular degeneration: multicountry observational study. Pharmacoeconomics. 2008;26(1):57-73.

20 C. Vitae Jordi Monés Monés J, Amselem L, Serrano A, García M, Hijano M. Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results. Eye Jun;23(6): Amselem L, Pulido JS, Gunduz K, García-Arumí J, Monés J. Infrared reflectance in choroidal melanomas and its correlation with fundus autofluorescence. Br J Ophthalmol Nov;92(11): [Pubmed] Ruiz-Moreno JM, Arias-Barquet L, Armadá-Maresca F, Boixadera-Espax A, García-Layana A, Gómez-Ulla-de-Irazazábal F, Monés-Carilla J, Piñero-Bustamante A, Suárez-de-Figueroa M. [Guidelines of clinical practice of the SERV: treatment of exudative agerelated macular degeneration (AMD)] Arch Soc Esp Oftalmol Jul;84(7): Arias L. Monés J. Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration. Clinical Ophthalmology 2010: Arias L, Monés J. Ranibizumab in the treatment of choroidal neovascularization on the border of an inferior staphyloma associated with tilted disc syndrome. Clin Ophthalmol Apr 26;4: Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group. ( Jordi Monés as in the GENEVA Study Group). Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology Jun;117(6): e3. Epub 2010 Apr Jonas J, Paques M, Monés J, Glacet-Bernard A. Retinal vein occlusions. Dev Ophthalmol. 2010;47: Epub 2010 Aug 10. Review.

21 C. Vitae Jordi Monés Biarnés M, Monés J, Villalbí JR, Arias L. As-needed treatment with ranibizumab 0.5 mg in patients with neovascular age-related macular degeneration. Eur J Ophthalmol May-Jun;21(3): doi: /EJO PMID: [PubMed - indexed for MEDLINE] Monés J. A Review of Ranibizumab Clinical Trial Data in Exudative Age-Related Macular Degeneration and How to Translate It into Daily Practice. Ophthalmologica. 2011;225(2): doi: / Epub 2010 Oct Zur D, Fischer N, Tufail A, Monés J, Loewenstein A.Postsurgical cystoid macular edema. Eur J Ophthalmol Nov 11;21(S6): [Epub ahead of print] Biarnés M, Monés J, Arias L, Villalbí JR. An Update on Geographic Atrophy in Age-Related Macular Degeneration Optometry and Vision Science. Optometry and Vision Science. Optom Vis Sci Apr 28. [Epub ahead of print] Coscas G, Loewenstein A, Augustin A, Bandello F, Battaglia M, Lanzetta P, Monés J, de Smet M, Soubrane G, Staurenghi G. Management of Retinal Vein Occlusion Consensus Document. Ophthalmologica 2011;226: Biarnés M, Monés J, Trindade F, Alonso J, Arias L. Intra and interobserver agreement in the classification of fundus autofluorescence patterns in geographic atrophy secondary to age-related macular degeneration Graefes Arch Clin Exp Ophthalmol Apr;250(4): Epub 2011 Oct Monés J, Biarnés M, Trindade F. Hyporeflective wedge-shaped band in geographic atrophy secondary to age-related macular degeneration: an

22 C. Vitae Jordi Monés 22 underreported finding. Ophthalmology Jul;119(7): Epub 2012 Mar Monés J, Biarnés M, Trindade F, Arias LL, Alonso J. Does foveal swelling exist in patients with foveal sparing secondary to geographic atrophy in dry AMD? (submitted for publication to Ophthalmology) Monés J, Biarnés M, Trindade F, Casaroli-Marano R. FUSION regimen: ranibizumab in treatment-naïve patients with exudative agerelated macular degeneration and relatively good baseline visual acuity. Graefes Arch Clin Exp Ophthalmol Dec;250(12): Epub 2012 Apr Monés J, Biarnés M, Trindade F, Arias L, Alonso J. Optical Coherence Tomography Assessment of Apparent Foveal Swelling in Patients with Foveal Sparing Secondary to Geographic Atrophy. Ophthalmology Jan 3. doi:pii: S (12) /j.ophtha [Epub ahead of print] PMID: [PubMed - as supplied by publisher] L. Arias Barquet and J. Monés. New treatment protocols and follow-up in patients with exudative age-related macular degeneration. Archivos de la Sociedad Española de Oftalmología. Volume 87. Supplement 1. December Lanzetta P. Holz F. Monés J. Querques G. Stanga P. Veritti D. Barbone F. Brusaferro S. Isola M. Intravitreal Injections: A Healthcare Failure Modes and Effects Analysis. Ophthalmologica (DOI: / ) Monés J, Biarnés M, Badal J. Bimonthly half-dose ranibizumab in large pigment epithelial detachment and retinal angiomatous proliferation with high risk of retinal pigment epithelium tear: a case

23 C. Vitae Jordi Monés 23 report. Clin Ophthalmol. 2013;7: doi: /OPTH.S Epub 2013 Jun Monés J. as a participant of a round table of participant leaders. Advocating for Improved treatment and Outcomes for Wet Age_retaled Macular Degeneration. A report based on an International Expert Summit. Convened in Berlin, Germany November The Angiogenesis Foundation Alfredo García-Layana, Luis Arias, Marta S. Figueroa, Monés J. Araiz, José María Ruiz-Moreno, José Garcia-Aruní, Francisco Gómez- Ulla, María Isabel López-Gálvez, Francisco Cabrera-López, José Manuel García Campos, Jordi Monés, Enrique Cervera, Félix Armadá, Miguel Ángle Serrano, Juan Donate, Roberto Gallego-Pinazo. Guía clínica de Expertos sobre el Manejo de la Degeneración Macular Asociada a la Edad Exudativa. Revista Española de Patología Macular. Volumen IV. Nº4. Noviembre de SCIENTIFIC PRESENTATIONS: 9.1. Spanish Meetings: Monés i Carilla JM, Ruiz Bulumar JL.: "Uso de la Mezlocilina tópica en el Tratamiento del Absceso Corneal por Pseudomonas". "LXIII CONGRESO NACIONAL DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGIA". Oviedo, September Monés JM: "Lesiones predisponentes. Profilaxis del desprendimiento de la retina". "III CURSO DEL DESPRENDIMIENTO DE RETINA Y VITREO. INSTITUTO CASTANERA". Barcelona, October Monés i Carilla JM, Rodriguez i Prats JL, Iglesias i Touriño E: "Afectació Ocular en la Neurofibromatosi de Von Reckinghausen". "VII JORNADES MÈDIQUES DEL VALLÈS. ACADÈMIA DE CIÈNCIES MÈDIQUES DE CATALUNYA I BALEARS". Sabadell, November 1987.

24 C. Vitae Jordi Monés Monés i Carilla JM, Soler i Tomàs JR, Iglesias i Touriño E: "Tractament de l'abscés Cornial Bacterià Resistent als Antibiòtics Convencionals". "VII JORNADES MÈDIQUES DEL VALLÈS. ACADÈMIA DE CIÈNCIES MÈDIQUES DE CATALUNYA I BALEARS". Sabadell, November Vilaplana i Blanch D, Soler i Tomàs JR, Monés i Carilla JM, Sena i Dutrenit JM: "Fotocoagulació Làser en la Profilaxi del Desprendiment de la Retina". "VII JORNADES MÈDIQUES DEL VALLÈS. ACADÈMIA DE CIÈNCIES MÈDIQUES DE CATALUNYA I BALEARS". Sabadell, November Monés i Carilla, JM, Samaan M: "Goniotomía ab interno y trabeculotomía ab externo con trabeculectomía". "LXIV CONGRESO DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGIA". Palma de Mallorca, October Monés J, Corcóstegui B: "Videoangiografia amb indocianina verda - oftalmoscopi de làser d'scanning (VICV - SLO) en la degeneració macular associada a l'edat (DMAE) forma exudativa." "NOVES TÉCNIQUES D'EXPLORACIÓ I DIAGNÒSTIC EN OFTALMOLOGIA". La Seu D'Urgell, April Monés J, Corcóstegui B: " Videoangiografia amb indocianina verda - oftalmoscopi de làser d'scanning (VICV - SLO). Estudi i diagnòstic de les malalties inflamatòries coroidals." "NOVES TÉCNIQUES D'EXPLORACIÓ I DIAGNÒSTIC EN OFTALMOLOGIA". La Seu D'Urgell, April Monés J, García Arumí J, Adán A: "Estudio y diagnóstico de las coroiditis mediante la videongiografía indocianina verde - SLO." "LXX CONGRESO DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA". Tenerife, September Monés J, Mateo C, Corcóstegui B: "Detección y clasificación de las membranas neovasculares coroideas en la DMAE mediante

25 C. Vitae Jordi Monés 25 videoangiografía ICV - SLO. "LXX CONGRESO DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA". Tenerife, September Monés J, Corcóstegui B, Durán N: "Patrones cicrculatorios coroideos submaculares en la DMAE." "LXX CONGRESO DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA". Tenerife, September Monés J, Corcóstegui B: "Efecte a distància de la fotocoagulació amb làser de diode: una complicació o una estratègia terapeútica?" "25è CONGRÉS DE LA SOCIETAT CATALANA D'OFTALMOLOGIA". Barcelona, December Jordi Monés, Andreu Coret: Técnica combinada de implante secundario de LIO de cámara posterior por incisión corneal con vitrectomía pars plana y fijación transescleral. III CONGRESO DE LA SOCIEDAD ESPAÑOLA DE RETINA Y VITREO. Madrid, February 21-22, Jordi Monés, Andreu Coret, Josep Ramon Soler: Recolocación interna con fijación escleral de LIO luxada a cámara vítrea mediante vitrectomía posterior. III CONGRESO DE LA SOCIEDAD ESPAÑOLA DE RETINA Y VITREO. Madrid, February 21-22, Jordi Monés i Carilla, Andreu Coret Novoa: Técnica combinada de cirugía del agujero macular y facoemulsificación e implante de LIO de CP 12º CONGRESO SECOIR. Santander, April 23-26, Jordi Monés i Carilla, Josep Ramon Soler i Tomás: Técnica de implante 2ºde LIO-CP con fijación transescleral mediante vitrectomía posterior. 12º CONGRESO SECOIR. Santander, April 23-26, J. Monés, F. Huste, IH Tercero: Tècnica d implant secundari de LIO amb fixació transescleral amb vitrectomia posterior 4ª BIENNAL DE VIDEO OFTALMOLOGIA. Girona, June 28, J. Monés, JR Soler Tomàs, JA Cardona: Tècnica combinada

26 C. Vitae Jordi Monés 26 de cirurgia de forat macular i facoemulsificació i implant de LIO-CP 4ª BIENNAL DE VIDEO OFTALMOLOGIA. Girona, June 28, Jordi Monés Carilla, Andrés Coret. Recolocación interna de LIO luxada a cámara vítrea mediante vitrectomía posterior y fijación transecleral. LXXIII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA". Granada, September 24-28, José Ramon Soler Tomás, Jordi Monés Carilla. Técnica combinada de cirugía de agujero macular y facoemulsificación de la catarata con implante plegable de cámara posterior. LXXIII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA". Granada, September 24-28, Jordi Monés Carilla. Vitrectomía posterior sin suturas 74 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA. Alicante, September 30 - October 4, Jordi Monés i Carilla Técnica de reparación inmediata de luxación de núcleo durante la facoemulsificación: vitrectomía posterior e implante de lente intraocular con fijación escleral a través de pequeña incisión. 74 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA. Alicante, 30 Sept - Oct 4, Jordi Monés: Terapia Fotodinámica en DAME exudativa: Resultados de pacientes en Uso compasivo. 76 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA. Madrid, October, Jordi Monés I cols. Teràpia Fotodinàmica en DMAE: resultants de pacients en Fase d ús Compassiu. 31 CONGRÉS DE LA SOCIETAT CATALANA D OFTALMOLOGIA. Barcelona, November (PRESENTATIONS and LECTURES are presented together from this point in the section 11.2)

27 C. Vitae Jordi Monés International Meetings: Sena Dutrenit JM, Vilaplana D, Soler JR, Monés JM: "Resultados de la Fotocoagulación Láser". "IX CURS INTERNACIONAL D'OFTALMOLOGIA DEL INSTITUT BARRAQUER". Barcelona, May David R. Guyer, Carmen A. Puliafito, Jordi M. Monés: "Indocyanine-Green Digital Angiography and Dye-Enhanced Diode Laser Photocoagulation of Choroidal Neovascularization". "ADVANCES IN OCULAR DRUG THERAPY: A PRACTICAL PERSPECTIVE. Massachusetts Eye and Ear Infirmary. Harvard Medical School. Boston, Massachusetts. USA, March 9, David R. Guyer, Carmen A. Puliafito, Jordi M. Monés: "Indocyanine-Green Digital Angiography and Dye-Enhanced Diode Laser Photocoagulation of Choroidal Neovascularization". "1991 WILMER RESIDENTS ASSOCIATION MEETING". THE Wilmer Institute. John Hopkins University, School of Medicine. Baltimore, Maryland. USA. April 25-27, Wendall C. Bauman, Jordi M. Monés, Jean-Jacques Tritten, Charles P. Lin, Evangelos Gragoudas, Carmen A. Puliafito: "Transpupillary Phthalocyanine Photodynamic Therapy of Experimental Posterior Malignant Melanoma". "1991 ANNUAL MEETING OF THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, ARVO". Sarasotta, Florida. USA. April 28 - May 2, Jordi M. Monés, William J. Woods and Carmen A Puliafito: "Retinal Toxicity of Hyaluronidase and Thimerosal injected into the Vitreous Body of the Rabbit". "1991 ANNUAL MEETING OF THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, ARVO". Sarasotta, Florida. USA. April 28 - May 2, 1991.

28 C. Vitae Jordi Monés Carmen A. Puliafito, David R. Guyer, Jordi M. Monés, Yaffa Weaver: "Indocyanine-Green Digital Angiography and Dye-Enhanced Diode Laser Photocoagulation of Choroidal Neovascularization". "1991 ANNUAL MEETING OF THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, ARVO". Sarasotta, Florida. USA. April 28-May 2, Ephraim Friedman, Jordi M. Monés: "The use of Indocyanine-Green in evaluating the Choroidal Circulation". "MASSACHUSETTS EYE AND EAR ALUMNI ASSOCIATION. ANNUAL CLINICAL AND SCIENTIFIC MEETING". Boston, Massachusetts. USA. May 16, David R. Guyer, Carmen A. Puliafito, Jordi M. Monés: "Indocyanine-Green Dye Enhanced Diode Laser Photocoagulation of Choroidal Neovascularization". "MASSACHUSETTS EYE AND EAR ALUMNI ASSOCIATION. ANNUAL CLINICAL AND SCIENTIFIC MEETING". Boston, Massachusetts. USA. May 16, Wendall C. Bauman, Jean-Jacques Tritten, Jordi M. Monés, Charles P. Lin, Evangelos Gragoudas, Carmen A. Puliafito: "Transpupillary PhotodynamicTherapy of Experimental Malignant Melanoma". "MASSACHUSETTS EYE AND EAR ALUMNI ASSOCIATION. ANNUAL CLINICAL AND SCIENTIFIC MEETING". Boston, Massachusetts. USA. May 16, Jordi M. Monés, David R. Guyer, Carmen A. Puliafito, Ephraim Friedman. "Indocyanine-Green Angiography in Choroidal Diseases". "1991 SCHEPENS INTERNATIONAL SOCIETY MEETING". Madrid, May 27-31, Jordi M. Monés, Wendall C. Bauman, Jean-Jacques Tritten, Charles P. Lin, Carmen A. Puliafito, Evangelos Gragoudas: "Phthalocyanine Photodynamic Treatment of Experimental Posterior Malignant Melanoma". "1991 SCHEPENS INTERNATIONAL SOCIETY MEETING". Madrid, May 27-31, 1991.

29 C. Vitae Jordi Monés Carmen A. Puliafito, David R. Guyer, Jordi M. Monés: "Digital Indocyanine-Green Angiography in retinal vascular diseases". "1991 ANNUAL MEETING OF THE AMERICAN ACADEMY OF OPHTHALMOLOGY". Anaheim, California. USA. October 13-17, Corcóstegui B, Monés JM: "Indocyanine videangiography with Scanning Laser Ophthalmoscope of large choroidal vessels in exudative age-related macular degeneration." "1994 ANNUAL MEETING OF THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, ARVO". Sarasotta, Florida. USA. May 1-6, Jordi M. Monés, Borja Corcóstegui: "Submacular choroidal vascular patterns in exudative age-related macular degeneration." "4th INTERNATIONAL SYMPOSIUM ON OCULAR CIRCULATION AND NEOVASCULARIZATION". Budapest, Hungary, May 22-26, Jordi Monés i Carilla, Josep Ramon Soler i Tomàs: Implante secundario con fijación transescleral mediante Vitrectomía Posterior CURSO INTERNACIONAL INSTITUTO BARRAQUER. Barcelona, June 9-11, Jordi Monés, Andreu Coret, Josep Ramon Soler: Recolocación interna con fijación escleral de LIO luxada a cámara vítrea mediante vitrectomía posterior. CURSO INTERNACIONAL INSTITUTO BARRAQUER. Barcelona, June 9-11, JR Soler Tomàs, J Monés, A Cardona, F. Huste: Anillos intracapsulares de tensión. Aplicaciones CURSO INTERNACIONAL INSTITUTO BARRAQUER. Barcelona, June 9-11, Monés JM: Pars plana vitrectomy and scleral fixation of foldable intraocular lens through small incision during complicated pahcoemulsification of dense cataract with intravitreal nuclear fragments luxation. XVIth CONGRESS OF THE ESCRS. Nice, September 6-9, 1998.

30 C. Vitae Jordi Monés Monés J and the VIP Study Group. Photodynamic therapy (PDT) with Verteporfin of subfoveal choroidal neovascularization in agerelated macular degeneration: Study design and baseline characteristics in the VIP randomized clinical trial. Invest Ophthalmol Vis Sci 40 (4) (Suppl): Monés JM. Reunión de casos clínicos: Retina y Vítreo. Andorra, January Monés JM. Principle Aspects of Clinical Trials of Photodynamic Therapy with Verteporfin (Visudyne TM ): Phase I and II, and phase III (TAP and VIP Study) in the treatment of CNV secondary to AMD y Pathologic Myopia. International Symposium Ocular Pharmacology. and Pharmaceutics. Lisbon, February 12, Monés JM. One-year Angiographic Outcomes and Safety Following Photodynamic Therapy with Verteporfin (Visudyne ) for subfoveal choroidal neovascularization in AMD Results of Two Randomized Phase III Clinical Trials (TAP Investigation) International Symposium Ocular Pharmacology. and Pharmaceutics. Lisbon, February 12, Monés JM. One-year Angiographic Outcomes and Safety Following Photodynamic Therapy with Verteporfin (Visudyne ) for subfoveal choroidal neovascularization in AMD Results of Two Randomized Phase III Clinical Trials (TAP Investigation) VI Mediterranean Ophthalmological Society Congress and VI Michaelson Symposium on Ocular Circulation and Neovascualrization. Jerusalem, Israel, May 24, Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Pathologic Myopia Using Verteporfin (Visudyne tm ); One-year Results VIP Report #1. The Retina Society 33 RD Annual Meeting. Coral Gables, FLA, USA, November 30 - December 3, 2000.

31 C. Vitae Jordi Monés Polypoidal Choroidal Vasculopathy in recurrent CNV after PDT. The Retina Society 34 rd Annual Meeting. Chiacago, USA October (It was going to be presented, Meeting Cancelled due to September 11 th 2001) Safety of multiple consecutive areas of light application during treatment of CNV with PDT. Reinaldo Castillo, Javier Moreno,Gilberto Rosales, Fernanda Vaz, Jordi Monés. Euretina Meeting. Barcelona, May, Photodynamic therapy in myopic CNV. Euretina Meeting. Barcelona, May, A New Automated Quantified Macular Metamorphopsia Measurement in CNV treated with PDT. 25th ANNUAL MACULA SOCIETY MEETING. Barcelona, June, Analysis of safety data of three randomized Trials of Verteporfin therapy in the treatment of neovascular AMD XXIIIrd Congress of the Club Jules Gonin in Montreux, Switzerland, 31 August - 4 Sep, (PRESENTATIONS and LECTURES are presented together from this point in the section 11.2) 10. TEACHING ACTIVITIES and INVITED LECTURES: Organization of Scientific Courses: Co-organization Curso " NUEVAS TÉCNICAS DE EXAMEN DEL FONDO DE OJO: LA OFTALMOSCOPÍA CON LÁSER DE BARRIDO (SLO)". Directores del Curso: Jordi Monés, Borja Corcóstegui. Centro Retina Vitreo, Barcelona, October 23, Fundator del Club Angiográfico Fluoresceina Indocianina, Club FLIN

Sitemap